Clinical Trial Update: Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction [Phase 2, Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 2/3 clinical trial evaluating intracoronary administration of adult human mesenchymal stem cells for safety and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Yonsei University | Conditions: Acute Myocardial Infarction | Phase 2, Phase 3 | Status: COMPLETED